Haleon plc has a 52 week low of $7.89 and a 52 week high of $10.80. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. About Haleon ...

The projected fair value for Haleon is UK£5.19 based on 2 Stage Free Cash Flow to Equity Current share price of UK£3.91 suggests Haleon is potentially 25% undervalued Analyst price target for ...

Haleon plc has a fifty-two week low of $7.89 and a fifty-two week high of $10.80. The firm has a market cap of $43.94 billion, a PE ratio of 28.54, a P/E/G ratio of 2.70 and a beta of 0.28.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion).

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Futura Medical PLC - Guildford, Surrey-based sexual health products - Shares rise 4.5% on Wednesday as Futura reports positive results from a 'sensory' study of its WSD4000 treatment for sexual ...

Shares of Haleon PLC HLN advanced 2.52% to £3.94 Monday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.41% to 8,768.01.

The 7,500-square-foot space, which boasts views of the ocean and Boardwalk, can seat 300 people ...